Emulsions, microemulsions, and lipid-based drug delivery systems for drug solubilization and delivery-part I: Parenteral applications

Water-Insoluble Drug Formulation, Second Edition

Volumn , Issue , 2008, Pages 195-226

  Cannon, John B ^a   Shi, Yi ^a   Gupta, Pramod ^b  

^a ABBOTT LABORATORIES   (United States)

^b BAUSCH AND LOMB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123270321     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (121)

1. Abuja, P.M. and Albertini, R. (2001) Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin. Chim. Acta, 306: 1-17.
2. Akkar, A., Namsolleck, P., Blaut, M., and Muller, R.H. (2004) Solubilizing poorly soluble antimycotic agents by emulsification via a solvent-free process. AAPS PharmSciTech., Article 24.
3. Alford, K.M., Gales, M.A., Gales, B.J., and Ramgopal, V. (1994) Acute renal failure with amphotericin b in 20% lipid emulsion. ASHP Midyear Clinical Meeting, 29: 415.
4. Allen, T.M., Hansen, C., and Rutledge, J. (1989) Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim. Biophys. Acta, 981: 27-35.
5. Ames, M.M. and Kovach, J.S. (1982) Parenteral formulation of hexamethylmelamine potentially suitable for use in man. Cancer Treat. Rep., 66: 1579-1581.
6. Antolovich, M., Prenzler, P.D., Patsalides, E., McDonald, S., and Robards, K. (2002) Methods for testing antioxidant activity. Analyst, 127: 183-198.
7. Arakane, K., Hayashi, K., Naito, N., Nagano, T., and Hirobe, M. (1995) pH lowering in liposomal dispersions induced by phospholipid peroxidation. Chem. Pharm. Bull., 43: 1755-1758.
8. Attwood, D. and Florence, A.T. (1985) Surfactant Systems. Chapman & Hall, New York, pp. 469-568.
9. Azevedo, C.H.M., Carvalho, J.P., Valduga, C.J., and Maranhão, R.C. (2005) Plasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patient with ovarian carcinoma. Gynecol. Oncol., 97: 178-182.
10. Behan, M., O'Connell, D., Mattrey, R.F., and Carney, D.N. (1993) Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results. Am. J. Roentgenol., 160: 399-405.
11. Benita, S., Friedman, D., and Weinstock, M. (1986) Physostigmine emulsion: a new injectable controlled release delivery system. Int. J. Pharm., 30: 47-55.
12. Biber, B., Johannesson, G., Lennander, O., Martner, J., Sonander, H., and Werner, O. (1984) Intravenous infusion of halothane dissolved in fat. Hemodynamic effects in dogs. Acta Anesthesiol. Scand., 28: 385-389.
13. Caillot, D., Chavanet, P., Casasnovas, O., Solary, E., Zanetta, G., Buisson, M., Wagner, O., Cuisenier, B., Bonnin, A., Camerlynck, P., et al. (1992) Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B. Eur. J. Clin. Microbiol. Infect. Dis., 11: 722-725.
14. Carl, P., Hogskilde, S., Nielsen, J.W., Sorensen, M.B., Lindholm, M., Karlen, B., and Backstrom, T. (1990) Pregnanolone emulsion. A preliminary pharmacokinetic and pharmacodynamic study of a new intravenous anaesthetic agent. Anaesthesia, 45: 189-197.
15. Chavanet, P.Y., Garry, I., Charlier, N., Caillot, D., Kisterman, J.P., D'Athis, M., and Portier, H. (1992) Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis. Brit. Med. J., 305: 921-925.
16. Chiang, C.-C., Longer, M., Tyle, P., Fessler, D., and Shetty, B. (1995) Formulation development of an oral dosage form for an HIV protease inhibitor, AG1284. Int. J. Pharm., 117: 197-207.
17. Collins-Gold, L.C., Lyons, R.T., and Bartholow, L.C. (1990) Parenteral emulsions for drug delivery. Adv. Drug Del. Rev., 5: 189-208.
18. Constantinides, P.P., Tustian, A., and Kessler, D.R. (2004) Tocol emulsion for drug solubilization and parenteral delivery. Adv. Drug Deliv. Rev., 56: 1243-1255.
19. Cui, G., Wang, L., Davis, P.J., Kara, M., and Liu, H. (2006) Preparation and physical characterization of a novel marine oil emulsion as a potential new formulation vehicle for lipid soluble drugs. Int. J. Pharm., 325: 180-185.
20. Davis, S.S. (1995) Drug delivery applications of multiphase systems. Multiphase systems for oral and parenteral drug delivery: Physical and biopharmaceutical aspects. 37th Annual Inter. Industrial Pharm. R&D Conference, Merrimac, WI, June 5-9.
21. Davis, S.S., Washington, C., West, P., Illum, L., Liversidge, G., Sternson, L., and Kirsch, R. (1987) Lipid emulsions as drug delivery systems. Ann NY Acad. Sci., 507: 75-88.
22. Derjaguin, B.V. and Landau, L.D. (1941) Theory of the stability of strongly lyophobic sols and of the adhesion of strongly charged particles in solutions of electrolytes. Acta Physicochim., 14: 633-662.
23. Dietz, N.J., Cascella, P.J., Houglum, J.E., Chappell, G.S., and Sieve, R.M. (1988) Phenobarbital stability in different dosage forms: alternatives for elixirs. Pharm. Res., 5: 803-805.
24. Doenicke, A., Kugler, A., Vollmann, N., Suttmann, H., and Taeger, K. (1990) [Etomidate using a new solubilizer. Experimental clinical studies on venous tolerance and bioavailability] (Germany). Anaesthesist, 39: 475-480.
25. Dorlhiac-Llacer, P.E., Marquezini, M.V., Toffoletto, O., Carneiro, R.C.G., Maranhão, R.C., and Chamone, D.A.F. (2001) In vitro cytotoxicity of the LDE: daunorubicin complex in acute myelogenous leukemia blast cells. Braz. J. Med. Biol. Res., 34: 1257-1263.
26. Dundee, J.W. and Clarke, R.S.J. (1989). Propofol. Eur. J. Anaesthesiol., 6: 5-22.
27. El Sayed, A.A.A. and Repta, A.J. (1983) Solubilization and stabilization of an investigational antineoplastic drug (NSC-278214) in an intravenous formulation using an emulsion vehicle. Int. J. Pharm., 13: 303-312.
28. Fee, J.P.H., Dundee, J.W., Collier, P.S., and McClean, E. (1984) Bioavailability of intravenous diazepam. Lancet, 2: 813.
29. Floyd, A.G. (1999) Top ten considerations in the development of parenteral emulsions. PSTT, 2: 134-143
30. Forster, D., Washington, C., and Davis, S.S. (1988) Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes. J. Pharm. Pharmacol., 40: 325-328.
31. Fukushima, S., Kishimoto, S., Takeuchi, Y., and Fushima, M. (2000) Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin. Adv. Drug Deliv. Rev., 45: 65-75.
32. Gasco, M.R., Pattarino, F., and Lattanzi, F. (1990) Long-acting delivery systems for peptides: reduced plasma testosterone levels in male rats after a single injection. Int. J. Pharm., 62: 119-123.
33. Gates, C. and Pinney, R.J. (1993) Amphotericin B and its delivery by liposomal and lipid formulations. J. Clin. Pharm. Ther., 18: 147-153.
34. Gray, H.S.J., Holt, B.L., Whitaker, D.K., and Eadsforth, P. (1992) Preliminary study of apregnanolone emulsion (KABI 2213) for i.v. induction of general anaesthesia. Br. J. Anaesth., 68: 272-276.
35. Griffin, W.C. (1949) Classification of surface active agents by HLB. J. Soc. Cosmetic Chem., 1: 311-326.
36. Halbaut, L., Barbe, C., Aroztegui, M., and de la Torre, C. (1997) Oxidative stability of semi-solid excipient mixtures with corn oil and its implication in the degradation of vitamin A. Int. J. Pharm., 147: 31-10.
37. Hanauske, A.R., Goedhals, L., Gelderblom, H., Lee, Y., Awada, A., Vermorken, J.B., Bolling, C., Rui-Garcia, A., Pratt, J., and Stewart, M.B. (2005) Tocosol® paclitaxel and cremophorel® -paclitaxel: the pharmacokinetic comparison shows that a new paclitaxel formulation leads to increased drug exposure. Eur. J. Cancer Suppl., 3: 427.
38. Handa, T., Eguchi, Y., and Miyajima, K. (1994) Effects of cholesterol and cholesteryl oleate on lipolysis and liver uptake of triglycerides/phosphatidylcholine emulsions in rats. Pharm. Res., 11: 1283-1287.
39. Handbook of Pharmaceutical Excipients (1994) Wade, A., and Weller, P.J. (eds.), Pharmaceutical Press (London); pp. 352, 372, 377, 475.
40. Hanna, G., Saewert, D., Shorr, J., Flaim, K., Leese, P., Kopperman, M., and Wolf, G. (1994) Preclinical and clinical studies on lymph node imaging using perflubron emulsion. Artif. Cells Blood Substit. Immobil. Biotechnol., 22: 1429-1439.
41. Hansrani, P.K., Davis, S.S., and Groves, M.J. (1983) The preparation and properties of sterile intravenous emulsions. J. Parent. Sci. Technol., 37: 145-150.
42. Helson, L.A. (1984) Phase I study of vitamin E and neuroblastoma. In Vitamins, Nutrition and Cancer, Prasa, L., ed., Krager, Basel, pp. 274-281.
43. Hering, W.. Schlecht, R., Geisslinger, G., Biburger, G., Dinkel, M., Brune, K., and Ruegheimer, E. (1995) EEG analysis and pharmacodynamic modelling after intravenous bolus injection of eltanolone (pregnanolone). Eur. J. Anaesthesiol., 12: 407-415.
44. Herman, C.J. and Groves, M.J. (1992) Hydrolysis kinetics of phospholipids in thermally stressed intravenous lipid emulsion formulations. J. Pharm. Pharmacol., 44: 539-542.
45. Herman, C.J. and Groves, M.J. (1993) The influence of free fatty acid formation on the pH of phospholipidstabilized triglyceride emulsions. Pharm. Res., 10: 774-776.
46. Hogskilde, S., Nielsen, J.W., Carl, P., and Sorenson, M. (1987a) Pregnanolone emulsion. Anaesthesia, 42: 586-590.
47. Hogskilde, S., Wagner, J., Carl, P., and Sorenson, M. (1987b) Anesthetic properties of pregnanolone emulsion. Anaesthesia, 42: 1045-1050.
48. Hwang, S.R., Lim, S.J., Park, J.S., and Kim, C.K. (2004) Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Int. J. Pharm., 276: 175-183.
49. Ivancev, K., Lunderquist, A., Isaksson, A., Hochbergs, P., and Wretlind, A. (1989) Clinical trials with a new iodinated lipid emulsion for computed tomography of the liver. Acta Radiol., 30: 449-457.
50. Johannesson, G., Alm, P., Biber, B., Lennander, O., and Werner, O. (1984) Halothane dissolved in fat as intravenous anesthetic to rats. Acta Anesthesiol. Scand., 28: 381-384.
51. Jumaa, M. and Muller, B.W. (1998) The stabilization of parenteral fat emulsion using non-ionic ABA copolymer surfactant. Int. J. Pharm., 174: 29-37.
52. Junping, W., Takayama, K., Nagai, T., and Maitani, Y. (2003) Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol. Int. J. Pharm., 251: 13-21.
53. Kam, E., Abdul-Latif, M.S., and McCluskey, A. (2004) Comparison of propofol-lipuro with propofol mixed with lidocaine 10 mg on propofol injection pain. Anesthesia, 59: 1167-1169.
54. Kawakami, S., Yamashita, F., and Hashida, M. (2000) Disposition characteristics of emulsions and incorporated drugs after systemic or local injection. Adv. Drug Del. Rev., 45: 77-88.
55. Keipert, P.E. (1995). Use of Oxygent (R), a perfluorochemical-based oxygen carrier, as an alternative to intraoperative blood transfusion. Artif. Cells, Blood Substit., Immobil. Biotechnol., 23: 381-394.
56. Kirsch, R.L. and Ravin, L.J. (1987) Polyene Antibiotic Emulsion Formulation. US Patent 4, 707, 470
57. Kulka, P.J., Bremer, F., and Schuttler, J. (1993) [Anesthesia induction using etomidate in a lipid emulsion] (Germany), Anaesthesist, 42: 205-209.
58. Kurihara, A., Shibayama, Y., Mizota, A., Yasuno, A., Ikeada, M., and Hisaoka, M. (1996) Pharmacokinetics of highly lipophilic autitumor agent palmitoyl Rhizoxin incorporated in lipid emulsion in rats. Biol. Pharm. Bull., 19: 252-258.
59. Lamb, K.A., Washington, C., Davis, S.S., and Denyer, S.P. (1991) Toxicity of amphotericin B emulsion to cultured canine kidney cell monolayers. J. Pharm. Pharmacol., 43: 522-524.
60. Lang, J.K. and Vigo-Pelfrey, A. (1993) Quality control of liposomal lipids with special emphasis on peroxidation of phospholipids and cholesterol. Chem. Phys. Lipids, 64: 19-29.
61. Laubli, M.W. and Bruttel, P.A. (1986) Determination of the oxidative stability of fats and oils comparison between the active oxygen method and the rancimat method. J. Am. Oil Chem. Soc., 63: 792-795.
62. Lee, M.-J., Lee, M.-H., and Shim, C.-K. (1995) Inverse targeting of drugs to reticuloendothelial system-rich organs by lipid microemulsion emulsified with poloxamer 338. Int. J. Pharm., 113: 175-187.
63. Levy, M.Y., Langerman, L., Gottschalk-Sabag, S., and Benita, S. (1989) Side effect evaluation of a new diazepam formulation venous sequalae reduction following i.v. injection of diazepam emulsion in rabbits. Pharm. Res., 6: 510-516.
64. Levy, M.Y., Polacheck, I., Barenholz, Y., and Benita, S. (1995) Efficacy evaluation of a novel submicron miconazole emulsion in a murine Cryptococcosis model. Pharm. Res., 12: 223.
65. Lidgate, D.M., Fu, R.C., Byars, N.E., Foster, L.C., and Felitman, J.S. (1989) Formulation of vaccine adjuvant muramyldipeptides. 3. Processing optimization, characterization, and bioactivity of an emulsion vehicle. Pharm. Res., 6: 748-752.
66. Lidgate, D.M., Trattner, T., Shultz, R.M., and Maskiewicz, R. (1992) Sterile filtration of a parenteral emulsion. Pharm. Res., 9: 860-863.
67. Liu, F. and Liu, D. (1995) Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs. Pharm. Res., 12: 1060-1064.
68. Lopez-Berestein, G. (1988) Liposomal amphotericin b in antimicrobial therapy. In: Liposomes as Drug Carriers, G. Gregoriadis, ed., John Wiley & Sons, New York, p. 345.
69. Lovell, M.W., Johnson, H.W., and Gupta, P.K. (1995) Stability of a less-painful intravenous emulsion of clarithromycin. Int. J. Pharm., 118: 47-54.
70. Lovell, M.W., Johnson, H.W., Hui, H.-W., Cannon, J.B., Gupta, P.K., and Hsu, C.C. (1994) Less-painful emulsion formulations for intravenous administration of clarithromycin. Int. J. Pharm., 109: 45-57.
71. Lundberg, B. (1994) The solubilization of lipophilic derivatives of podophyllotoxins in sub-micron sized lipid emulsions and their cytotoxic activity against cancer cells in culture. Int. J. Pharm., 109: 73-81.
72. Malcolmson, C. and Lawrence, M.J. (1993) Comparison of the incorporation of model steroids into non-ionic micellar and microemulsion systems. J. Pharm. Pharmacol., 45: 141-143.
73. Matsuo, H. (1998) Preliminary evaluation of AS-013 (prodrug of prostaglandin E1) administration for chronic peripheral arterial occlusive disease. Int. J. Angiol., 7: 22-24.
74. Minagawa, T., Kohno, Y., Suwa, T., and Tsuji, A. (1994) Entrapping efficiency of an oil-in-water emulsion containing isocarbacyclin methyl ester (TEI-9090) in dog and human Sera. Pharm. Res., 11: 1677-1679.
75. Muller, R.H., Lucks, J.S., Herbort, J., and Couvreur, P. (1991) Improved treatment of liver metastasis by titanocene dichloride using an emulsion carrier. Arch. Pharma., 324: P37.
76. Muller, R.H., Schmidt, S., Buttle, I., Akkar, A., Schmitt, J., and Bromer, S. (2004) SolEmuls-novel technology for formulation of i.v. emulsions with poorly soluble drugs. Int. J. Pharm., 269: 293-302.
77. Nakamoto, Y., Fujiwara, M., Naguchi, T., Kimura, T., Muranishi, S., and Sezaki, H. (1975) Studies on pharmaceutical modification of anticancer drugs. I. Enhancement of lymphatic transport of mitomycin C by parenteral emulsion. Chem. Pharm. Bull., 23: 2232-2238.
78. Naylor, H.C. and Burlingham, A.N. (1985) Pharmacokinetics of diazepam emulsion. Lancet, 1: 518-519.
79. Oh, I., Chi, S.-C., Vishnuvajjala, B.R., and Anderson, B.D. (1991) Stability and solubilization of oxathiin carboxanilide a novel anti-HIV agent. Int. J. Pharm., 73: 23-32.
80. Paborji, M., Riley, C.M., and Stella, V.J. (1988) A novel use of Intralipid for the parenteral delivery of perilla ketone (NSC-348407), an investigational cytotoxic drug with a high affinity for plastic. Int. J. Pharm., 42: 243-249.
81. Park, K.M. and Kim, C.K. (1999) Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery. Int. J. Pharm., 181: 173-179.
82. Pathak, Y.V., Rubinstein, A., and Benita, S. (1990) Enhanced stability of physostigmine salicylate in submicron o/w emulsion. Int. J. Pharm., 65: 169-175.
83. Physicians Desk Reference (1995) Medical Economics Co., Montvale, NJ, pp. 1019, 2436, 2618.
84. Physicians Desk Reference (1999) Medical Economics Co., Montvale, NJ, pp. 2063, 2079, 3411.
85. Porter, N.A. (1984) Chemistry of lipid peroxidation. Meth. Enzymol., 105: 273.
86. Prankerd, R.J., Frank, S., and Stella, V.J. (1988) Preliminary development and evaluation of a parenteral formulation of penclomedine (NSC-338720); 3, 5-dichloro-2, 4-dimethoxy-6-trichloromethylpyridine): A novel, practically water insoluble cytotoxic agent. J. Parent. Sci. Technol., 42: 76-81.
87. Prankerd, R.J. and Stella, V.J. (1990) The use of oil-in-water emulsions as a vehicle for parenteral administration. J. Parent. Sci. Technol., 44: 139-149.
88. Reddy, P.R. and Venkateswarlu, V. (2005) Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion. J. Drug Target, 13: 543-553.
89. Rodriguez, D.G., Maria, D.A., Fernandes, D.C., Claudete, J.V., Couto, R.D., Ibanez, O.C.M., and Maranhão, R.C. (2005) Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies. Cancer Chemother. Pharmacol., 55: 565-576.
90. Santos Magalhaes, N.S., Cave, G., Seiller, M., and Benita, S. (1991) The stability and in vitro release kinetics of a clofibride emulsion. Int. J. Pharm., 76: 225-237.
91. Sarker, D.K. (2005) Engineering of nanoemulsions for drug delivery. Cancer Drug Deliv., 2: 297-310.
92. Sevanian, A. and Ursini, F. (2000) Lipid peroxidation in membranes and low-density lipoproteins: similarities and differences. Free Rad. Biol. Med., 29: 306-311.
93. Sherman, P. (1983) Rheological properties of emulsions. In Encyclopedia of Emulsion Technology, P. Becher, ed., vol. II, Marcel Dekker, New York, p. 405.
94. Stella, V.J., Umprayn, K., and Waugh, W. (1988) Development of parenteral formulations of experimental cytotoxic agents. I. Rhizoxin (NSC-332598). Int. J. Pharm., 43: 191-199.
95. Strickley, R.G. and Anderson, B.D. (1993) Solubilization and stabilization of an anti-HIV thiocarbamate, NSC 629243, for parenteral delivery, using extemporaneous emulsions. Pharm. Res., 10: 1076-1082.
96. Swern, D. (1995) Reactions of fats and fatty acids. In Bailey's Industrial Oil and Fat Products, Vol. 1, 4th ed., John Wiley & Sons, New York, pp. 130-161.
97. Tadros, T., Izquierdo, P., Esquena, J., and Solans, C. (2004) Formation and stability of nano-emulsions. Adv. Coll. Interface Sci., 108-109: 303-318.
98. Takino, T., Konishi, K., Takadura, Y., and Hashida, M. (1994) Long circulating emulsion carrier systems for highly lipophilic drugs. Biol. Pharm. Bull., 17: 121-125.
99. Takino, T., Nagahama., E., Sakaeda, T., Yamashita, F., Takakura, Y., and Hashida, M. (1995) Pharmacokinetics disposition analysis of lipophlic drugs injected with various lipid carriers in the single-pass rat liver perfusion system. Int. J. Pharm., 114: 43-54.
100. Tanigawa, N., Shimomatsuya, T., Takahashi, K., Inomata, Y., Tanaka, K., Satomura, K., Hikasa, Y., Hashida, M., Muranishi, S., and Sezaki, H. (1987) Treatment of cystic hygroma and lymphangioma with the use of bleomycin fat emulsion. Cancer, 60: 741-749.
101. Tarr, B.D., Sambandan, T.G., and Yalkowsky, S.H. (1987) A new parenteral emulsion for the administration of taxol. Pharm. Res., 4: 162-165.
102. Teixeira, R.S., Curi, R., Maranhão, R.C. (2004) Effects on Walker 256 tumour of Carmustine associated with a cholesterol-rich microemulsion (LDE). J. Pharm. Pharmacol., 56: 909-914.
103. Tibell, A., Larsson, M., and Alvestrand, A. (1993) Dissolving intravenous cyclosporin Ain afat emulsion carrier prevents acute renal side effects in the rat. Transpl. Int., 6: 69-72.
104. Tibell, A., Linholm, A., Sawe, J., and Norrlind, B. (1995) Cyclosporin A in fat emulsion carriers: experimental studies on pharmacokinetics and tissue distribution. Pharmacol. Toxicol., 76: 115-121.
105. Toguchi, H., Ogawa, Y., and Shimamoto, T. (1990) Effects of the physicochemical properties of the emulsion formulation on the bioavailability of ethyl 2-chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl] propionate in rats. Chem. Pharm. Bull., 38: 2797-2800.
106. Ton, M.N., Chang, C., Carpentier, Y.A., and Deckelbaum, R.J. (2005) In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides. Clin. Nutr., 24: 492-501.
107. Tyle, P. and Cady, S.M. (1990) Systained release multiple emulsions for bovine somatotropin delivery. Proc. Int. Sym. Cont. Rel. Bioact. Mater., 17: 49-50.
108. Valduga, C.J., Fernandes, D.C., Lo Prete, A.C., Azevedo, C.H.M., Rodrigues, D.G., Maranhão, R.C. (2003) Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein as vehicle for etoposide. J. Pharm. Pharmacol., 55: 1615-1622.
109. VanBerkel, T.J.C., Kar Kruijt, J., De Schmidt, P.C., and Bijsterbosch, M.K. (1991) Receptor-dependent targeting of lipoproteins to specific cell types of the liver. In Lipoproteins as carriers of pharmacological agents, Shaw, J.M., ed., Marcel Dekker, New York, p. 225-249.
110. Van Bloois, L., Dekker, D.D., and Crommelin, D.J.A. (1987) Solubilization of lipophilic drugs by amphiphiles improvement of the apparent solubility of almitrine bismesylate by liposomes mixed micelles and o-w emulsions. Acta Pharm. Technol., 33: 136-139.
111. Venkatraman, S., Awni, W.M., Jordan, K., and Rahman, Y.E. (1990) Pharmacokinetics of two alternative dosage forms for cyclosporine liposomes and intralipid. J. Pharm. Sci., 79: 216-219.
112. Verwey, E.J.W. and Overbeek, J.T.G. (1948) Theory of the Stability of Lyophobic Colloids. Elsevier, Amsterdam.
113. Von Corswant, C., Thoren, P., and Engstrom, S. (1998). Triglyceride-based microemulsion for intravenous administration of sparingly soluble substances. J. Pharm. Sci., 87: 200-208.
114. Von Dardel, O., Mebius, C., Mossberg, T., and Svensson, B. (1983) Fat emulsion as a vehicle for diazepam. A study of 9492 patients. Br. J. Anesth., 55: 41-47.
115. Walstra, P. (1983) Formation of emulsions. In Encyclopedia of Emulsion Technology, Vol. I, P. Becher, ed., Marcel Dekker, New York, p. 57.
116. Ward, D.S., Norton, R.J., Guivarc'h, P.-H., Litman, R.S. Bailey, P.L. (2002) Pharmacodynamics and pharmacokinetics of propofol in medium-chain triglyceride emulsion. Anesthesiology, 97: 140-1408.
117. Washington, C., Koosha, F., and Davis, S.S. (1993) Physicochemical properties of parenteral fat emulsions containing 20% triglyceride; intralipid and Ivelip. J. Clin. Pharm. Ther., 18: 123-131.
118. Williams, K.J. and Tall, A.R. (1988) Interactions of liposomes with lipoproteins. In Liposomes as Drug Carriers, G. Gregoriadis, ed., John Wiley & Sons, New York, p. 93.
119. Woodle, M.C. and Lasic, D.D. (1992) Sterically stabilized liposomes. Biochim. Biophys. Acta, 113: 171-199.
120. Yamaguchi, T. and Mizushima, Y. (1994) Lipid microspheres for drug delivery from the pharmaceutical viewpoint. Crit. Rev. Drug Carrier Systems, 114: 215-229.
121. Yamaguchi, T., Nishizaki, K., Itai, S., Hayashi, H., and Oshima, H. (1995) Physicochemical characterization of parenteral lipid emulsion. Pharm. Res., 12: 342-347.